Vanderbilt University School of Medicine

Emeson, Ronald B. , Ph.D.
Professor of Pharmacology
Joel G. Hardman Chair in Pharmacology
Professor of Psychiatry
Professor of Molecular Physiology and Biophysics

Lab Url: N/A

Phone Number: (615) 936-1688, (615) 936-3705

Email Address:ron.emeson@vanderbilt.edu

Emeson, Ronald's picture

Office Address   Mailing Address

8140 Medical Research Building III

8140 MRB III 37232-8548


Research Keywords
molecular neurobiology, gene expression, receptor diversity, neurotransmitters, RNA editing, knockout

Research Specialty
Molecular neurobiology

Research Description
The research interests of our laboratory focus on the field of molecular neurobiology. By integrating the disciplines of peptide biochemistry, cell biology, animal physiology and molecular biology, we hope to gain a better understanding of the cellular and molecular processes underlying neuronal communication in normal and pathophysiological disease states.

Our laboratory is examining the molecular mechanisms involved in the editing of numerous RNA transcripts in the mammalian central nervous system. RNA editing is a post-transcriptional modification in which specific adenosine residues are converted to inosine moieties (A-to-I editing) via the actions of double-stranded RNA-specific adenosine deaminases. As a result of these deamination events, the coding potential of RNAs can be subtly altered to change as little as a single amino acid residue in resultant proteins. In the case of glutamate-gated ion channels, RNA editing can dramatically alter both the ion permeation and electrophysiological properties of these ionotropic receptors. Since glutamate-gated channels are critically involved in processes of excitatory neurotransmission, slight alterations in RNA editing patterns have profound effects upon the normal neurophysiology of the brain. RNA editing events within the 2C-subtype of serotonin receptor can modulate the efficacy by which this seven transmembrane-spanning receptor can couple to its specific intracellular signaling pathways. Since this serotonin receptor has been implicated in a number of neuropsychiatric disease states, including depression and schizophrenia, aberrant RNA editing patterns may play an important role in the etiology of these disorders. Recent studies from our laboratory have also demonstrated that overexpression of ADAR2, a double-stranded RNA-specific adenosine deaminase that catalyzes A-to-I editing results in excessive obesity in transgenic mice, suggesting that misregulation of this post-transcriptional modification can result in severe pathophysiological defects. Current research efforts in the laboratory focus upon the regulation of RNA editing as well as biochemical and bioinformatics strategies for the identification of additional RNAs that are substrates for this type of RNA processing event.

Publications
Hood, JL, Emeson, RB. Editing of Neurotransmitter Receptor and Ion Channel RNAs in the Nervous System. Curr Top Microbiol Immunol, , , 2011.

O''Neil, RT, Emeson, RB. Quantitative analysis of 5HT(2C) receptor RNA editing patterns in psychiatric disorders. Neurobiol Dis, , , 2011.

Morabito, MV, Abbas, AI, Hood, JL, Kesterson, RA, Jacobs, MM, Kump, DS, Hachey, DL, Roth, BL, Emeson, RB. Mice with altered serotonin 2C receptor RNA editing display characteristics of Prader-Willi syndrome. Neurobiol Dis, 39, 169-80, 2010.

Morabito, MV, Ulbricht, RJ, O''Neil, RT, Airey, DC, Lu, P, Zhang, B, Wang, L, Emeson, RB. High-throughput multiplexed transcript analysis yields enhanced resolution of 5-hydroxytryptamine 2C receptor mRNA editing profiles. Mol Pharmacol, 77(6), 895-902, 2010.

Olaghere da Silva, UB, Morabito, MV, Canal, CE, Airey, DC, Emeson, RB, Sanders-Bush, E. Impact of RNA Editing on Functions of the Serotonin 2C Receptor in vivo. Front Neurosci, 4, 26, 2010. PMCID:2858556

Stefl, R, Oberstrass, FC, Hood, JL, Jourdan, M, Zimmermann, M, Skrisovska, L, Maris, C, Peng, L, Hofr, C, Emeson, RB, Allain, FH. The solution structure of the ADAR2 dsRBM-RNA complex reveals a sequence-specific readout of the minor groove. Cell, 143(2), 225-37, 2010.

Jacobs, MM, Fogg, RL, Emeson, RB, Stanwood, GD. ADAR1 and ADAR2 expression and editing activity during forebrain development. Dev Neurosci, 31(3), 223-37, 2009. PMCID:2692045

Morabito, MV, Emeson, RB. RNA editing as a therapeutic target for CNS disorders. Neuropsychopharmacology, 34(1), 246, 2009.

Rula, EY, Lagrange, AH, Jacobs, MM, Hu, N, Macdonald, RL, Emeson, RB. Developmental modulation of GABA(A) receptor function by RNA editing. J Neurosci, 28(24), 6196-201, 2008. PMCID:2746000

Rula, EY, Emeson, RB. Mouse Models to Elucidate the Functional Roles of Adenosine-to-Inosine Editing. Methods Enzymol, 424, 333-67, 2007.

Singh, M, Kesterson, RA, Jacobs, MM, Joers, JM, Gore, JC, Emeson, RB. Hyperphagia-mediated Obesity in Transgenic Mice Misexpressing the RNA-editing Enzyme ADAR2. J Biol Chem, 282(31), 22448-59, 2007.

Thompson, BJ, Washington, MK, Kurre, U, Singh, M, Rula, EY, Emeson, RB. Protective Roles of alpha-Calcitonin and beta-Calcitonin Gene-Related Peptide in Spontaneous and Experimentally Induced Colitis. Dig Dis Sci, , , 2007.

Feng, Y, Sansam, CL, Singh, M, Emeson, RB. Altered RNA editing in mice lacking ADAR2 autoregulation. Mol Cell Biol, 26(2), 480-8, 2006. PMCID:1346902

Huebner, AK, Schinke, T, Priemel, M, Schilling, S, Schilling, AF, Emeson, RB, Rueger, JM, Amling, M. Calcitonin deficiency in mice progressively results in high bone turnover. J Bone Miner Res, 21(12), 1924-34, 2006.

Stefl, R, Xu, M, Skrisovska, L, Emeson, RB, Allain, FH. Structure and Specific RNA Binding of ADAR2 Double-Stranded RNA Binding Motifs. Structure, 14(2), 345-55, 2006.

Xu, M, Wells, KS, Emeson, RB. Substrate-dependent Contribution of Double-stranded RNA-binding Motifs to ADAR2 Function. Mol Biol Cell, 17(7), 3211-20, 2006. PMCID:1552048

Emeson, RB, Morabito, MV. Food fight: the NPY-serotonin link between aggression and feeding behavior. Sci STKE, 2005(277), pe12, 2005.

Sansam, CL and RB Emeson. mRNA Editing. In: Encyclopedia of Life Sciences, John Wiley & Sons, Ltd: Chichester , [doi:10.1038/npg.els.0005041] , 2005.

Stefl, R, Skrisovska, L, Xu, M, Emeson, RB, Allain, FH. Resonance assignments of the double-stranded RNA-binding domains of adenosine deaminase acting on RNA 2 (ADAR2). J Biomol NMR, 31(1), 71-2, 2005.

Dawson, T. Renee, Sansam, Christopher L., Emeson, Ronald B.. Structure and sequence determinants required for the editing of ADAR2 substrates. J Biol Chem, 279, 4941-4951, 2004.

Schinke, T, Liese, S, Priemel, M, Haberland, M, Schilling, AF, Catala-Lehnen, P, Blicharski, D, Rueger, JM, Gagel, RF, Emeson, RB, Amling, M. Decreased bone formation and osteopenia in mice lacking alpha-calcitonin gene-related peptide. J Bone Miner Res, 19(12), 2049-56, 2004.

Maison, SF, Emeson, RB, Adams, JC, Luebke, AE, Liberman, MC. Loss of alpha CGRP reduces sound-evoked activity in the cochlear nerve. J Neurophysiol, 90(5), 2941-9, 2003.

Sansam, Christopher L, Wells, K Sam, Emeson, Ronald B. Modulation of RNA editing by functional nucleolar sequestration of ADAR2. Proc Natl Acad Sci U S A, 100(24), 14018-23, 2003. PMCID:283538

Berg, KA, Cropper, JD, Niswender, CM, Sanders-Bush, E, Emeson, RB, Clarke, WP. RNA-editing of the 5-HT(2C) receptor alters agonist-receptor-effector coupling specificity. Br J Pharmacol, 134(2), 386-92, 2001. PMCID:1572953

El Meskini, R, Jin, L, Marx, R, Bruzzaniti, A, Lee, J, Emeson, R, Mains, R. A signal sequence is sufficient for green fluorescent protein to be routed to regulated secretory granules. Endocrinology, 142(2), 864-73, 2001.

Niswender, C M, Herrick-Davis, K, Dilley, G E, Meltzer, H Y, Overholser, J C, Stockmeier, C A, Emeson, R B, Sanders-Bush, E. RNA editing of the human serotonin 5-HT2C receptor. alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology, 24(5), 478-91, 2001.

Gott, JM, Emeson, RB. Functions and mechanisms of RNA editing. Annu Rev Genet, 34, 499-531, 2000.

Singh M and Emeson RB. Adenosine to Inosine RNA Editing: Substrates and Consequences. RNA Editing: Frontiers in Molecular Biology. (BL Bass, ed.) Oxford University Press:London, , 109-138, 2000.

Liu, Y, Emeson, RB, Samuel, CE. Serotonin-2C receptor pre-mRNA editing in rat brain and in vitro by splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase ADAR1. J Biol Chem, 274(26), 18351-8, 1999.

Lu, J T, Son, Y J, Lee, J, Jetton, T L, Shiota, M, Moscoso, L, Niswender, K D, Loewy, A D, Magnuson, M A, Sanes, J R, Emeson, R B. Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci, 14(2), 99-120, 1999.

Niswender, CM, Copeland, SC, Herrick-Davis, K, Emeson, RB, Sanders-Bush, E. RNA editing of the human serotonin 5-hydroxytryptamine 2C receptor silences constitutive activity. J Biol Chem, 274(14), 9472-8, 1999.

Rueter, S M, Dawson, T R, Emeson, R B. Regulation of alternative splicing by RNA editing. Nature, 399(6731), 75-80, 1999.

Niswender, C M, Sanders-Bush, E, Emeson, R B. Identification and characterization of RNA editing events within the 5-HT2C receptor. Ann N Y Acad Sci, 861, 38-48, 1998.

Rueter S and RB Emeson. Adenosine to Inosine Conversion in mRNA. Modification and editing of RNA: the alteration of RNA structure and function. (H. Grosjean and R. Benne, eds.) ASM Press:East Norwalk, CT, , 343-361, 1998.

Sanes, J.R., E.D. Apel, R.W. Burgess, R.B. Emeson, G. Feng, M. Gautam, D. Glass, R.M. Grady, E. Krejci, J.W. Lichtman, J.T. Lu, J. Massoulie, J.H. Miner, L.M. Moscoso, Q. Nguyen, M. Nichol, P.G. Noakes, B.L. Patton, Y.J. Son, G.D. Yancopoulos and H. Zhou. Development of the neuromuscular junction: genetic analysis in mice. J Physiol Paris , 92, 167 172, 1998.

Bass, BL, Nishikura, K, Keller, W, Seeburg, PH, Emeson, RB, O''Connell, MA, Samuel, CE, Herbert, A. A standardized nomenclature for adenosine deaminases that act on RNA. RNA, 3(9), 947-9, 1997. PMCID:1369539

Breyer, R M, Emeson, R B, Davis, L S, Breyer, M D. Structure and localization of the rabbit prostaglandin EP3 receptor. Adv Exp Med Biol, 400A, 261-8, 1997.

Burns, C M, Chu, H, Rueter, S M, Hutchinson, L K, Canton, H, Sanders-Bush, E, Emeson, R B. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature, 387(6630), 303-8, 1997.

Canton, H, Emeson, R B, Barker, E L, Backstrom, J R, Lu, J T, Chang, M S, Sanders-Bush, E. Identification, molecular cloning, and distribution of a short variant of the 5-hydroxytryptamine2C receptor produced by alternative splicing. Mol Pharmacol, 50(4), 799-807, 1996.

Emeson, R.B. Post-transcriptional regulation of calcitonin gene-related peptide (CGRP) mRNA production. Neurogenic Inflammation. (P. Geppetti and P. Holzer, eds.), CRC Press, Boca Raton, FL, , 15-30, 1996.

Simpson, L, Emeson, RB. RNA editing. Annu Rev Neurosci, 19, 27-52, 1996.

Rueter, S M, Burns, C M, Coode, S A, Mookherjee, P, Emeson, R B. Glutamate receptor RNA editing in vitro by enzymatic conversion of adenosine to inosine. Science, 267(5203), 1491-4, 1995.

Breyer, RM, Emeson, RB, Tarng, JL, Breyer, MD, Davis, LS, Abromson, RM, Ferrenbach, SM. Alternative splicing generates multiple isoforms of a rabbit prostaglandin E2 receptor. J Biol Chem, 269(8), 6163-9, 1994.

Yeakley, JM, Hedjran, F, Morfin, JP, Merillat, N, Rosenfeld, MG, Emeson, RB. Control of calcitonin/calcitonin gene-related peptide pre-mRNA processing by constitutive intron and exon elements. Mol Cell Biol, 13(10), 5999-6011, 1993. PMCID:364659

Emeson, RB, Yeakley, JM, Hedjran, F, Merillat, N, Lenz, HJ, Rosenfeld, MG. Posttranscriptional regulation of calcitonin/CGRP gene expression. Ann N Y Acad Sci, 657, 18-35, 1992.

Rosenfeld, MG, Emeson, RB, Yeakley, JM, Merillat, N, Hedjran, F, Lenz, J, Delsert, C. Calcitonin gene-related peptide: a neuropeptide generated as a consequence of tissue-specific, developmentally regulated alternative RNA processing events. Ann N Y Acad Sci, 657, 1-17, 1992.

Emeson, RB, Hedjran, F, Yeakley, JM, Guise, JW, Rosenfeld, MG. Alternative production of calcitonin and CGRP mRNA is regulated at the calcitonin-specific splice acceptor. Nature, 341(6237), 76-80, 1989.

Rosenfeld, M, Crenshaw, E B, Emeson, R, Leff, S, Guise, J, Lira, S, Nelson, C, Nelson, C, Russo, A. Transcriptional and post-transcriptional strategies in neuroendocrine gene expression. Dev Biol (N Y 1985), 5, 317-34, 1988.

Emeson, RB, Eipper, BA. Characterization of pro-ACTH/endorphin-derived peptides in rat hypothalamus. J Neurosci, 6(3), 837-49, 1986.

Emeson, RB. Hypothalamic peptidyl-glycine alpha-amidating monooxygenase: preliminary characterization. J Neurosci, 4(10), 2604-13, 1984.


Postdoctoral Position Available
No

Postdoctoral Position Details
N/A

Updated Date
10/21/2010



Vanderbilt University is committed to principles of equal opportunity and affirmative action.
Copyright 2008 Vanderbilt University School of Medicine
The office of Biomedical Research Education & Training All rights reserved.
For questions or problems concerning this page, please submit a help ticket.